Integrated genomic analysis to identify druggable targets for pancreatic cancer

According to the National Comprehensive Cancer Network and the American Society of Clinical Oncology, the standard treatment for pancreatic cancer (PC) is gemcitabine and fluorouracil. Other chemotherapeutic agents have been widely combined. However, drug resistance remains a huge challenge, leading...

Descripción completa

Detalles Bibliográficos
Autores principales: Mugiyanto, Eko, Adikusuma, Wirawan, Irham, Lalu Muhammad, Huang, Wan-Chen, Chang, Wei-Chiao, Kuo, Chun-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752886/
https://www.ncbi.nlm.nih.gov/pubmed/36531045
http://dx.doi.org/10.3389/fonc.2022.989077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752886/
https://www.ncbi.nlm.nih.gov/pubmed/36531045
http://dx.doi.org/10.3389/fonc.2022.989077

Ejemplares similares